Association between four microRNA binding site-related polymorphisms and the risk of warfarin-induced bleeding complications

Main Article Content

Maryam Hosseindokht
Mohammadali Boroumand
Rasoul Salehi
Ali Mandegary
Azita Hajhosseini Talasaz
Leyla Pourgholi
Hamed Zare
Shayan Ziaee
Mohammadreza Sharifi

Abstract

Bleeding is the most serious complication of warfarin anticoagulation therapy and is known to occur even at patients with therapeutic international normalized ratio (INR) range. Recently, it has been shown that microRNAs play a significant role in pharmacogenetics by regulating genes that are critical for drug function. Interaction between microRNAs and these target genes could be affected by single-nucleotide polymorphisms (SNPs) located in microRNA-binding sites. This study focused on 3′-untranslated region (3′-UTR) SNPs of the genes involved in the warfarin action and the occurrence of bleeding complications in an Iranian population receiving warfarin. A total of 526 patients under warfarin anticoagulation therapy with responding to the therapeutic dose and maintenance of the INR in the range of 2.0-3.5 in three consecutive blood tests were included in the study. Four selected 3'-UTR SNPs (rs12458, rs7294, rs1868774 and rs34669593 located in GATA4, VKORC1, CALU and GGCX genes, respectively) with the potential to disrupt/eliminate or enhance/create microRNA-binding site were genotyped using a simple PCR-based restriction fragment length polymorphism (PCR-RFLP) method. Patients with the rs12458 AT or TT genotypes of the GATA4 gene had a lower risk of bleeding compared to patients with the AA genotype (adjusted OR: 0.478, 95% CI: 0.285-0.802, P= 0.005, OR: 0.416, 95% CI: 0.192-0.902, P= 0.026, respectively). 3'-UTR polymorphisms in other genes were not significantly associated with the risk of bleeding complications. In conclusion, the SNP rs12458A>T in the 3′UTR region of GATA4 is associated with the incidence of warfarin-related bleeding at target range of INR, likely by altering microRNA binding and warfarin metabolism. Further genetics association studies are needed to validate these findings before they can be implemented in clinical settings.

Article Details

How to Cite
Hosseindokht, M., Boroumand, M., Salehi, R., Mandegary, A., Hajhosseini Talasaz, A., Pourgholi, L., Zare, H., Ziaee, S., & Sharifi, M. (2019). Association between four microRNA binding site-related polymorphisms and the risk of warfarin-induced bleeding complications. EXCLI Journal, 18, 287-299. https://doi.org/10.17179/excli2019-1352
Section
Original articles